CUL4B

cullin 4B, the group of Cullins

Basic information

Region (hg38): X:120505920-120604074

Links

ENSG00000158290NCBI:8450OMIM:300304HGNC:2555Uniprot:Q13620AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • X-linked intellectual disability, Cabezas type (Strong), mode of inheritance: XL
  • X-linked intellectual disability, Cabezas type (Supportive), mode of inheritance: XL
  • X-linked intellectual disability, Cabezas type (Definitive), mode of inheritance: XL
  • X-linked intellectual disability, Cabezas type (Definitive), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Intellectual developmental disorder, X-linked, syndromic 15 (Cabezas type)XLGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Endocrine; Musculoskeletal; Neurologic8135271; 10978355; 11562927; 17236139; 17273978; 19377476; 20002452; 20014135; 24898194

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CUL4B gene.

  • X-linked_intellectual_disability_Cabezas_type (186 variants)
  • not_provided (127 variants)
  • CUL4B-related_disorder (84 variants)
  • Inborn_genetic_diseases (37 variants)
  • not_specified (27 variants)
  • Intellectual_disability (4 variants)
  • Seizure (2 variants)
  • Abnormal_sperm_morphology (1 variants)
  • Global_developmental_delay (1 variants)
  • Pettigrew_syndrome (1 variants)
  • Oligospermia (1 variants)
  • Short_stature (1 variants)
  • CUL4B-related_X-linked_intellectual_disability (1 variants)
  • Abnormal_facial_shape (1 variants)
  • Reduced_sperm_motility (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CUL4B gene is commonly pathogenic or not. These statistics are base on transcript: NM_001079872.2. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
5
clinvar
73
clinvar
8
clinvar
87
missense
2
clinvar
5
clinvar
125
clinvar
8
clinvar
2
clinvar
142
nonsense
10
clinvar
7
clinvar
17
start loss
0
frameshift
17
clinvar
9
clinvar
1
clinvar
27
splice donor/acceptor (+/-2bp)
5
clinvar
4
clinvar
1
clinvar
10
Total 34 26 132 81 10

Highest pathogenic variant AF is 0.000044694032

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CUL4Bprotein_codingprotein_codingENST00000404115 2151186
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.00000367125727031257300.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.771263140.4010.00002186077
Missense in Polyphen1077.4720.129081547
Synonymous-0.5221191121.060.000007901628
Loss of Function5.48035.00.000.00000254642

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003800.000185
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition subunit. CUL4B may act within the complex as a scaffold protein, contributing to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. Plays a role as part of the E3 ubiquitin-protein ligase complex in polyubiquitination of CDT1, histone H2A, histone H3 and histone H4 in response to radiation- induced DNA damage. Targeted to UV damaged chromatin by DDB2 and may be important for DNA repair and DNA replication. Required for ubiquitination of cyclin E, and consequently, normal G1 cell cycle progression. Regulates the mammalian target-of-rapamycin (mTOR) pathway involved in control of cell growth, size and metabolism. Specific CUL4B regulation of the mTORC1-mediated pathway is dependent upon 26S proteasome function and requires interaction between CUL4B and MLST8. {ECO:0000269|PubMed:14578910, ECO:0000269|PubMed:16322693, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:18235224, ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:19801544, ECO:0000269|PubMed:22118460}.;
Disease
DISEASE: Mental retardation, X-linked, syndromic, 15 (MRXS15) [MIM:300354]: A syndromic form of X-linked mental retardation characterized by severe intellectual deficit associated with short stature, craniofacial dysmorphism, small testes, muscle wasting in lower legs, kyphosis, joint hyperextensibility, pes cavus, small feet, and abnormalities of the toes. Additional neurologic manifestations include speech delay and impairment, tremor, seizures, gait ataxia, hyperactivity and decreased attention span. {ECO:0000269|PubMed:17236139, ECO:0000269|PubMed:17273978, ECO:0000269|PubMed:19377476, ECO:0000269|PubMed:20002452}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Nucleotide excision repair - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Mesodermal Commitment Pathway;DNA Repair;Post-translational protein modification;Metabolism of proteins;Neddylation;Recognition of DNA damage by PCNA-containing replication complex;DNA Damage Bypass;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Dual Incision in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Formation of TC-NER Pre-Incision Complex;Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Nucleotide Excision Repair (Consensus)

Recessive Scores

pRec
0.121

Intolerance Scores

loftool
rvis_EVS
-0.36
rvis_percentile_EVS
28.63

Haploinsufficiency Scores

pHI
0.874
hipred
Y
hipred_score
0.831
ghis
0.652

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.559

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cul4b
Phenotype
growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
G1/S transition of mitotic cell cycle;nucleotide-excision repair, DNA damage recognition;transcription-coupled nucleotide-excision repair;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, preincision complex assembly;nucleotide-excision repair, DNA incision, 5'-to lesion;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus;proteasomal protein catabolic process;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;neuron projection development;nucleotide-excision repair, DNA incision;histone H2A monoubiquitination;DNA damage response, detection of DNA damage;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;positive regulation of protein catabolic process;global genome nucleotide-excision repair;UV-damage excision repair;positive regulation of G1/S transition of mitotic cell cycle
Cellular component
nucleoplasm;cytosol;SCF ubiquitin ligase complex;cullin-RING ubiquitin ligase complex;Cul4B-RING E3 ubiquitin ligase complex;extracellular exosome;Cul4-RING E3 ubiquitin ligase complex
Molecular function
damaged DNA binding;protein binding;ubiquitin protein ligase binding;ubiquitin protein ligase activity